Depolarised expression of episialin (EMA, MUC1) in lung adenocarcinoma is associated with tumor progression

Anticancer Research

Volumn 18, Issue 3 B, 1998, Pages 1915-1920

  Guddo, Francesca ^a,g   Giatromanolaki, Alexandra ^b   Patriarca, Carlo ^c   Hilkens, John ^d   Reina, Clotilde ^a   Alfano, Rosa M ^c   Vignola, Antonio M ^a   Koukourakis, Michael I ^b   Gambacorta, Marcello ^e   Pruneri, Giancarlo ^f   Coggi, Guido ^c   Bonsignore, Giovanni ^a  

^a CNR   (Italy)

^b Hospital of Iraklion   (Greece)

^c II Cattedra Anat Patologica U   (Italy)

^d NETHERLANDS CANCER INSTITUTE   (Netherlands)

^e Ist Anat Patologica Osp N   (Italy)

^f III Cattedra Anat Patologica I   (Italy)

^g Istituto di Fisiopatologia Respiratoria   (Italy)

Author keywords

Adenocarcinoma; Episialin; Lung cancer; Metastasis; MUC 1; Squamous cell carcinoma

Indexed keywords

CA 15-3 ANTIGEN;

ANTIGEN EXPRESSION; ARTICLE; CANCER GROWTH; CANCER STAGING; CONTROLLED STUDY; DEPOLARIZATION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LUNG ADENOCARCINOMA; LUNG NON SMALL CELL CANCER; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; SQUAMOUS CELL CARCINOMA; ADENOCARCINOMA; DISEASE COURSE; LUNG TUMOR; METABOLISM; PATHOLOGY; RETROSPECTIVE STUDY;

ADENOCARCINOMA; CA-15-3 ANTIGEN; CARCINOMA, NON-SMALL-CELL LUNG; CARCINOMA, SQUAMOUS CELL; DISEASE PROGRESSION; HUMANS; IMMUNOHISTOCHEMISTRY; LUNG NEOPLASMS; LYMPHATIC METASTASIS; RETROSPECTIVE STUDIES;

EID: 15144341821     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Kanters SD.M, Lammers JWJ and Voest EE: Molecular and biological factors in the prognosis of non-small cell lung cancer. Eur Respir J 8: 1389-97, 1995.
2. Mountain CF: New prognostic factors in lung cancer. Biologic prophets of cancer cell aggression. Chest 108: 246-54, 1995.
3. Aznavoorian S, Murphy AN, Stetler-Stevenson WG and Liotta LA: Molecular aspects of tumor cell invasion and metastasis. Cancer 71: 1368-83, 1993.
4. Juliano RL and Varner JA: Adhesion molecules in cancer: the role of integrins. Curr Opin Cell Biol 5: 812-8, 1993.
5. Schwartz MA: Signaling by integrins: implications for tumorigenesis. Cancer Res 53: 1503-6, 1993.
6. Hilkens J, Ligtenberg MJ, Vos HL and Litvinov SV: Cell membrane-associated mucins and their adhesion-modulating property. Trends Biochem Sci 17: 359-63, 1992.
7. Wesseling J, van-der-Valk SW, Vos HL, Sonnenberg A and Hilkens J: Episialin (MUC1) overexpression inhibits integrin-mediated cell adhesion to extracellular matrix components. J Cell Biol 129: 255-65, 1995.
8. Ligtenberg MJ, Buijs F, Vos HL and Hilkens J: Suppression of cellular aggregation by high levels of episialin. Cancer Res 52: 2318-24, 1992.
9. Petersen OW and van-Deurs B: Characterization of epithelial membrane antigen expression in human mammary epithelium by ultrastructural immunoperoxidase cytochemistry. J Histochem Cytochem 34: 801-9, 1986.
10. Wesseling J, van-der-Valk SW and Hilkens J: A mechanism for inhibition of E-cadherin-mediated cell-cell adhesion by the membrane-associated mucin episialin/MUC1. Mol Biol Cell 7: 565-77, 1996.
11. Hudson MJH, Stamp GWH, Hollingsworth MA, Pignatelli M and Lalani EN: MUC1 expressed in PanC1 cells decreases adhesion to type 1 collagen but increases contraction in collagen lattices. Am J Pathol 145: 951-60, 1996.
12. Sawada T, Ho JJ, Chung YS, Sowa M and Kim YS: E-selectin binding by pancreatic tumor cells is inhibited by cancer sera. Int J Cancer 57: 901-7, 1994.
13. van-de-Wiel-van-Kemenade E, Ligtenberg MJ, de-Boer AJ, Buijs F, Vos HL, Melief CJ, Hilkens J and Figdor CG: Episialin (MUC1) inhibits cytotoxic lymphocyte-target cell interaction. J Immunol 151: 767-76, 1993.
14. McGuckin MA, Walsh MD, Hohn BG, Ward BG and Wright RG: Prognostic significance of MUC1 epithelial mucin expression in breast cancer.Hum Pathol 26: 432-9, 1995.
15. Ceriani RL, Chan CM, Baratta FS, Ozzello L, DeRosa CM and Habif DV: Levels of expression of breast epithelial mucin detected by monoclonal antibody BrE-3 in breast-cancer prognosis. Int J Cancer 51: 343-54,1992.
16. Seregni E, Botti C, Lombarde C, A. Cantoni A, Bogni A, Cataldo I and Bombardieri E: Pattern of mucin gene expression in normal and neoplastic lung tissues. Anticancer Res 16: 2209-13, 1996.
17. Behrens J, MM. Marcel MM, FM Van-Roy FM and Birchmeier W: Dissecting tumor cell invasion: epithelial cells acquire invasive properties after the loss of uvomorulin-mediated cell-cell adhesion. J Cell Biol 108: 2435-47, 1989.
18. Hynes RO: Integrins: versatility, modulation, and signaling in cell adhesion. Cell 69: 11-25, 1992.
19. Ohori NP, Coppola D and Landreneau RJ: CD44v6 expression in primary bronchioloalveolar carcinoma and conventional pulmonary adenocarcinoma.Mod Pathol 9: 507-12, 1996.
20. Kawano N, Osawa H, Ito T, Nagashima Y, Hirahara F, Inayama Y, Nakatani Y, Kimura S, Kitajima H, Koshikawa N, Miyazaki K and Kitamura H: Expression of gelatinase A, tissue inhibitor of metalloproteinases-2, matrilysin, and trypsin(ogen) in lung neoplasms: an immunohistochemical study. Hum Pathol 28: 613-22, 1997.
21. Clarke MR, Landreneau RJ, Finkelstein SD, Wu TT, Ohori P and Yousem SA: Extracellular matrix expression in metastasizing and nonmetastasizing adenocarcinomas of the lung. Hum Pathol 28: 54-9, 1997.
22. Fasano M, Sabatini MT, Wieczorek R, Sidhu G, Goswami S and Jagirdar J: CD44 and its v6 spliced variant in lung tumors: a role in histogenesis? Cancer 80: 34-41, 1997.